Vaccine Market Access in 100 Days: From Pipe Dream to Reality

Overcoming vaccine market access delays

The market access process for vaccines can dramatically prolong the time to market compared with other pharmaceuticals, partly due to complex and opaque pathways of National Immunization Technical Advisory Groups (NITAGs). Read this white paper and learn how to develop and submit a comprehensive global NITAG/Health Technology Assessment (HTA) package within 100 days of market authorization.